Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT01989013

Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy

We are studying & researching the effect of CranioSacral Integrative therapy on Parkinson's Diseased Patients for 3 months. With a therapeutic induction via manual CranioSacral integrative therapy for 90 minutes per session with a total of 2 session divided equally in a month (biweekly intervention). At the end of 3 months each patient will have total of 9 hours of CranioSacral Integrative therapy induced, we will document the symptoms and shortcomings of the patients at evaluation, before and after therapeutic treatment on a measured scale ranging from 1-10. Finally graphically and statistically measure the quality of change in the symptoms at the end of 3 months and provide executive summary of the research finding, which the investigators expect to be a positive one.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Parkinson's Disease Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Movement Disorders Nervous System Diseases Neurodegenerative Diseases Parkinson Disease Parkinsonian Disorders Synucleinopathies

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Naturalmed therapy

Ann Arbor, Michigan, 48104, United States

About this study

We are studying & researching the effect of CranioSacral I therapy on Parkinson's Disease

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • must be Diagnosed with Parkinson's Disease

Exclusion criteria

  • Anyone without Parkinson's Disease

Treatment and study plan

biweekly intervention

Other

10 step craniosacral therapy protocol through manual therapy at feet , thoracic diaphragm, neck and cranium

Other names: manual therapy

Primary outcomes

  1. reduction in tremors due to Parkinson's disease in the patient

    Time frame: 3 months

    Measurement of the tremors and quality of the coordination of the medial leminiscus system on 1-10 (1 being zero tremors and 10 being out of control tremors) scale at the evaluation and at beginning and at the end of each treatment session and in the end will provide a graphical and statistical display in the change in the tremors relative to the therapeutic induction

Secondary outcomes

  1. Quality of Proprioception

    Time frame: 3 months

    will evaluate the patients ability to move within space and time with certain precision and measure it on a scale of 1-10 (1 being very precise with fine motor movement and 10 being out of control fine motor movements)at the time of evaluation and at the beginning and end of each therapeutic treatment and finally document it graphically and statistically, the change in the overall motor movements like walking and quality of gait.

Other outcomes

  1. Overall emotional State and sleep quality

    Time frame: 3 months

    will evaluate the overall emotional and sleeping habits on the measurement scale of 1-10 where 1 being emotionally stable and positive with 8 hours of quality sleep and 10 being emotionally unstable and have less than 4 hours of sleep at night and at the end of research will graphically and statistically provide the outcome of the above mentioned measure.

Sponsors and collaborators

Lead sponsor

Zia, Al Raza

Indiv

Registry information

Important dates

Study start
2014
Primary completion
2025
Study completion
2025
First posted
Nov 20, 2013
Registry last updated
Jan 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.